Latest Breaking News On - Korea pharma - Page 1 : comparemela.com

Shield Therapeutics files for South Korean regulatory approval for Accrufer

Shield Therapeutics files for South Korean regulatory approval for Accrufer
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

South koreaUnited kingdomGreg madisonMinistry of foodShield therapeuticsKorea pharmaNew drug application

Audited results for the year ended 31 Dec 2023 | Company Announcement

Audited results for the year ended 31 Dec 2023 | Company Announcement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesHong kongNew zealandSouth koreaCity ofRepublic of koreaHans peter haslerCharlotte edgar alice woodingsJoyce allaireSantosh shanbhagPatrick birkholmAndy hurleyGreg madisonNorginebv norgineAosaikang pharmaceutical co ltd

Investegate | Company Announcement

Investegate | Company Announcement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofHong kongNew zealandNorginebv norgineGreg madisonPaul mcmanus alice woodingsJohn mullalyHans peter haslerPatrick birkholmLifesci advisorsPeel huntPharmaceuticals incEuropean unionCavendish capital markets ltdKorea pharma co ltd

Shield Therapeutics PLC says lead product expected to gain Korean regulatory approval in 2023

Shield Therapeutics PLC says lead product expected to gain Korean regulatory approval in 2023
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

South koreaRepublic of koreaAccrufer ferracruGreg madisonDrug administrationShield therapeuticsKorean foodNew drug applicationKorea pharma

Shield Therapeutics PLC surges as it inks licence agreement for Accrufer in South Korea

Under the deal with Korea Pharma Co Ltd, the company said it will receive an upfront payment of £0.5mln as well as £1.5mln upon first commercial sale.

South koreaGreg madisonKorea pharma co ltdKorea pharmaSmall capsHarma biotechShield therapeutics plcLon stxதெற்கு கொரியாகிரெக் மாடிசன்கொரியா பார்மாசிறிய தொப்பிகள்